Join our experts for case-based episodes that focus on bridging the gap between rural health and cardiovascular disease. Experts will explore ASCVD prevention and treatment by reviewing patient risk factors and determining ASCVD risk reduction strategies. This activity is designed to empower healthcare professionals with the knowledge and tools needed to make impactful decisions in cardiovascular care.
From Risk to Results: Cases in ASCVD Prevention and Treatment
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
Disclosure of Relevant Financial Relationships
Faculty Disclosure
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.Ty Gluckman, MD, faculty for this educational event, is a consultant OptumRx.
Rishi Wadhera, MD, faculty for this educational event, is a current consultant with Abbott Vascular and a former consultant with Chambercardio.
All of the relevant financial relationships listed for these individuals have been mitigated. No other speakers, authors, planners or content reviewers have any relevant financial relationship to disclose.
Target Audience
This activity is intended for cardiologists, lipidologists, primary care physicians, specialty and non-specialty nurse practitioners and physician associates, and pharmacists who care for patients with atherosclerotic cardiovascular disease.
Learning Objectives
After completing this activity, participants should be better able to:
- Develop strategies to implement a personalized treatment plan to reduce ASCVD risk
- Formulate collaboration strategies between academic and rural health providers to optimize ASCVD management
Accreditation and Credit Designation Statements
In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Partners for Advancing Clinical Education. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME
This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.CPE
This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Other
UK Healthcare CECentral certifies this activity for 1.00 hour of participation.CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.Disclaimer
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Provider(s)/Educational Partner(s)
This activity is jointly provided by the University of Kentucky and Partners for Advancing Clinical Education.
Commercial Support
This activity is supported by an unrestricted educational grant from Novartis.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date: